<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Little is known about the pathophysiology of <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C0001618" disease_type="Neoplastic Process" abbrv="">adrenocortical tumors</z:e> in adults </plain></SENT>
<SENT sid="1" pm="."><plain>Because loss of heterozygosity at the 11p15 locus has been described in <z:e sem="disease" ids="C1368871" disease_type="Neoplastic Process" abbrv="">childhood tumors</z:e>, particularly, in <z:e sem="disease" ids="C0001618" disease_type="Neoplastic Process" abbrv="">adrenocortical tumors</z:e>, associated with the <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> and because insulin-like growth factor-II (IGF-II) is a crucial regulator of fetal adrenal growth, we looked for structural analysis at the 11p15 locus and IGF-II gene expression in 23 <z:hpo ids='HP_0003745'>sporadic</z:hpo> adrenocortical adult <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>: 6 <z:mp ids='MP_0002038'>carcinomas</z:mp> (5 with <z:e sem="disease" ids="C0010481" disease_type="Disease or Syndrome" abbrv="">Cushing's syndrome</z:e> and 1 nonsecreting) and 17 benign <z:mpath ids='MPATH_270'>adenomas</z:mpath> (13 with <z:e sem="disease" ids="C0010481" disease_type="Disease or Syndrome" abbrv="">Cushing's syndrome</z:e>, 1 pure <z:chebi fb="3" ids="50113">androgen</z:chebi> secreting, and 3 nonsecreting) </plain></SENT>
<SENT sid="2" pm="."><plain>Twenty-one patients were informative at the 11p15 locus, and six (four <z:mp ids='MP_0002038'>carcinomas</z:mp> and two <z:mpath ids='MPATH_270'>adenomas</z:mpath>) of them (28.5%) exhibited 11p15 structural abnormalities in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> DNA (five, an <z:mp ids='MP_0008867'>uniparental disomy</z:mp> and one, a mosaicism) </plain></SENT>
<SENT sid="3" pm="."><plain>In a single case that could be further studied, a paternal isodisomy was observed </plain></SENT>
<SENT sid="4" pm="."><plain>Very high IGF-II <z:chebi fb="2" ids="33699">mRNA</z:chebi> contents were detected in seven <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (30%; 5 of the 6 <z:mp ids='MP_0002038'>carcinomas</z:mp> and 2 of the 17 <z:mpath ids='MPATH_270'>adenomas</z:mpath>) </plain></SENT>
<SENT sid="5" pm="."><plain>They were particularly found in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with <z:mp ids='MP_0008867'>uniparental disomy</z:mp> at the 11p15 locus </plain></SENT>
<SENT sid="6" pm="."><plain>Overall, a strong correlation existed between IGF-II <z:chebi fb="2" ids="33699">mRNA</z:chebi> contents and DNA demethylation at the IGF-II locus </plain></SENT>
<SENT sid="7" pm="."><plain>These data show that genetic alterations involving the 11p15 locus were highly frequent in <z:mp ids='MP_0002018'>malignant tumors</z:mp>, but found only in rare <z:mpath ids='MPATH_270'>adenomas</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>These results in combination with evidence for overexpression of IGF-II from the 11p15.5 locus suggest that abnormalities in structure and/or expression of the IGF-II gene play a role as a late event of a multistep process of <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
</text></document>